ASX LIMITED — Director's Dealing 2025

Mar 20, 2025

==> picture [481 x 5] intentionally omitted <==

==> picture [32 x 50] intentionally omitted <==

21 March 2025

Australian Securities and Investments Commission ASX Market Announcements Office Mr Benjamin Cohn-Urbach ASX Limited Senior Executive Leader, Market Infrastructure 20 Bridge Street Level 5, 100 Market Street SYDNEY NSW 2000 SYDNEY NSW 2000

APPENDIX 3Y – CHANGE OF DIRECTOR’S INTEREST NOTICE – DR HEATHER SMITH

Attached is an Appendix 3Y Change of Director’s Interest Notice for Dr Heather Smith.

Release of market announcement authorised by: Johanna O’Rourke

Group General Counsel and Company Secretary

20 Bridge Street Sydney NSW 2000 PO Box H224 Investor Support 13 12 79 Australia Square NSW 1215 asx.com.au

ASX Limited ABN 98 008 624 691

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	ASX Limited
ABN	98 008 624 691

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Heather Joy Smith
Date of last notice	3 April 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	21 March 2025
No. of securities held prior to change	3,807 fully paid ordinary shares directly heldjointly by Dr Martin Lee Parkinson and Dr HeatherJoySmith.
Class	Fully paid ordinary shares
Number acquired	63
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$4,227.93
No. of securities held after change	3,870 fully paid ordinary shares directly heldjointly by Dr Martin Lee Parkinson and Dr HeatherJoy Smith.
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	Issue of securities under the dividendreinvestment plan

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Detail of contract	Not applicable	Not applicable
	Nature of interest
	Name of registered holder(if issued securities)
	Date of change
	No. and class of securities to which interestrelated prior to change
	Note: Details are only required for a contract in relation to which theinterest has changed
	Interest acquired
	Interest disposed
	Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation
	Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed periodwhereprior written clearance was required?	No
If so, was prior written clearance provided toallow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on whatdate was this provided?	Not applicable

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011